Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Cancer: Cancer
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 75 results found since Jan 2013.
Prior Cancer in Patients with Ischemic Stroke: The Bergen NORSTROKE Study
Conclusions: The prevalence of prior cancer is higher in ISP than in the general population. ISPs with prior cancer are more prone to cardioembolism.
Source: Journal of Stroke and Cerebrovascular Diseases - September 27, 2013 Category: Neurology Authors: Henriette A. Selvik, Lars Thomassen, Nicola Logallo, Halvor Næss Tags: Original Articles Source Type: research
Predictive Value of Plasma d-Dimer Levels for Cancer-related Stroke: A 3-Year Retrospective Study
Background: Cerebrovascular disease is the second leading cause of central nervous system pathology in cancer patients. Cancer-associated hypercoagulation plays an important role in cancer-related stroke. The present study aims to test whether plasma d-dimer levels could predict comorbid malignancy in patients with ischemic stroke.Methods: Five hundred sixteen stroke patients with measured d-dimer levels and who were consecutively admitted to our stroke center from 2009 to 2012 were included. Cancer status was determined by medical chart, and 59 patients were identified to have active cancer. An additional 48 cancer patien...
Source: Journal of Stroke and Cerebrovascular Diseases - December 2, 2013 Category: Neurology Authors: Yi-Jen Guo, Ming-Hung Chang, Po-Lin Chen, Yu-Shan Lee, Yu-Chia Chang, Yi-Chu Liao Tags: Original Articles Source Type: research
Hyponatremia in the Prognosis of Acute Ischemic Stroke
Background: Hyponatremia is a risk factor for stroke and cardiovascular disease. Even mild hyponatremia is associated with increased 30-day mortality after myocardial infarction, and it has recently shown to increase the 3-year mortality after a stroke. In this work, we investigated both acute and chronic clinical outcomes after a stroke in hyponatremic patients.Methods: We reviewed all patients admitted between 2004 and 2011 with the diagnosis of acute ischemic stroke. Hyponatremia was defined as serum sodium level less than 135 mmol/L and recorded on admission. All hemorrhagic strokes were excluded. Data were analyzed us...
Source: Journal of Stroke and Cerebrovascular Diseases - August 19, 2013 Category: Neurology Authors: Bernardo Rodrigues, Ilene Staff, Gilbert Fortunato, Louise D. McCullough Tags: Original Articles Source Type: research
Smoking and Mortality in Stroke Survivors: Can We Eliminate the Paradox?
Conclusions: Stroke survivors who smoke have an increased risk of all-cause mortality, which is largely because of cancer mortality. Socioeconomic and clinical factors explain stroke survivors' higher risk of CVD mortality associated with smoking.
Source: Journal of Stroke and Cerebrovascular Diseases - January 17, 2014 Category: Neurology Authors: Deborah A. Levine, James M. Walter, Sudeep J. Karve, Lesli E. Skolarus, Steven R. Levine, Kristine A. Mulhorn Tags: Original Articles Source Type: research
Trends in Cancer Diagnoses among Inpatients Hospitalized with Stroke
Background: Cancer, by conferring a hypercoagulable state, may lead to an ischemic stroke. Relatively little is known about the prevalence and evolution of cancer among stroke patients over the last decade.Methods: We used the Nationwide Inpatient Sample to identify discharges with any International Classification of Diseases, Ninth Revision, diagnosis code for cancer and ischemic stroke from 1997 to 2006. We then calculated age-adjusted yearly acute ischemic stroke hospitalization rates among adult populations with and without cancer.Results: Prevalence of cancer among hospitalized stroke patients increased from 1997 to ...
Source: Journal of Stroke and Cerebrovascular Diseases - December 17, 2012 Category: Neurology Authors: Nerses Sanossian, Christina Djabiras, William J. Mack, Bruce Ovbiagele Tags: Original Articles Source Type: research
C-reactive Protein and Homocysteine Predict Long-term Mortality in Young Ischemic Stroke Patients
Conclusions: There is an independent association between CRP and homocysteine levels obtained several years after ischemic stroke in young adults and subsequent mortality, even when adjusting for traditional risk factors. This association seems to continue for at least 12 years after the measurements.
Source: Journal of Stroke and Cerebrovascular Diseases - June 3, 2013 Category: Neurology Authors: Halvor Naess, Harald Nyland, Titto Idicula, Ulrike Waje-Andreassen Tags: Original Articles Source Type: research
Three-Month Outcomes Are Poor in Stroke Patients with Cancer Despite Acute Stroke Treatment
Stroke risk is increased in cancer patients. Prognosis in these patients is poor, with higher in-hospital mortality and increased subsequent mortality. However, data on stroke in cancer patients are limited, specifically regarding acute stroke treatment and functional outcomes. We aim to determine the functional outcomes of cancer patients admitted with acute stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - November 23, 2016 Category: Neurology Authors: Shawna Cutting, Meagan Wettengel, James J. Conners, Bichun Ouyang, Katharina Busl Source Type: research
Risk of Ischemic Stroke and Major Bleeding in Patients With Atrial Fibrillation and Cancer
Background: Atrial fibrillation (AF) is an important risk factor for ischemic stroke. Cancer may increase the risk both of ischemic stroke and of bleeding. Less is known about risk of ischemic stroke and bleeding among cancer patients with AF, complicating the prevention of ischemic stroke in these patients. Methods: Register based cohort study comprising all Swedish patients hospitalized with a primary diagnosis of AF from July 1, 2005 until December 31, 2014. Patients with cancer diagnosis were compared to the rest of the cohort.
Source: Journal of Stroke and Cerebrovascular Diseases - December 26, 2019 Category: Neurology Authors: Sara Aspberg, Liyang Yu, Bruna Gigante, Karin E Smedby, Daniel E Singer Source Type: research
The Risk Factors for Death within 6 Months After Ischemic Stroke in Patients with Cancer
While the intravenous recombinant tissue plasminogen activator (rt-PA) therapy for acute ischemic stroke patients with cancer is recommended when survival of ≥ 6 months is expected, the risk factors for death and stroke recurrence within 6 months after stroke are not well known. Thus, we aimed to identify markers for death and recurrence risks within six months from stroke onset in patients with cancer.
Source: Journal of Stroke and Cerebrovascular Diseases - October 16, 2020 Category: Neurology Authors: Yoko Tsuchihashi, Takahiro Shimizu, Hisanao Akiyama, Yuta Hagiwara, Kaima Soga, Naoki Takao, Kenji Uchino, Toshiyuki Yanagisawa, Junji Yamauchi, Tomoo Sato, Yasuhiro Hasegawa, Yoshihisa Yamano Source Type: research
Understanding Coordinator Roles in Acute Stroke Care: A National Survey
Globally, stroke is a major contributor to death and disability.1 Evidence-based care in hospital after an acute stroke ensures improved survival and reduced disability, but care quality can vary.2,3 Clinical coordinators have an essential role in improving best-practice in trauma, cancer, diabetes, and heart failure conditions.4-7 Within stroke, coordinator roles are not new; in 1970, a study outlining the ‘Stroke Team’ model was published, which included a physician, nurse-coordinator and physical therapist.
Source: Journal of Stroke and Cerebrovascular Diseases - September 29, 2021 Category: Neurology Authors: Tara Purvis, Sandy Middleton, Anne W. Alexandrov, Monique F. Kilkenny, Skye Coote, Sarah Kuhle, Dominique A. Cadilhac Source Type: research
Treatment of Cryptogenic Stroke with Active Cancer with a New Oral Anticoagulant
Low-molecular weight heparin (LMWH) was shown to be effective and safe in treating venous thromboembolism, and generally used for stroke in cancer patients, but its effects on stroke are unclear. We compared clinical outcomes between LMWH and new oral anticoagulant (NOAC) in patients with cancer-related stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - August 23, 2017 Category: Neurology Authors: Ki-Woong Nam, Chi Kyung Kim, Tae Jung Kim, Sang Joon An, Kyungmi Oh, Sang-Bae Ko, Byung-Woo Yoon Source Type: research
Determination of Clinical Cut-Off Values for Serum Cystatin C Levels to Predict Ischemic Stroke Risk
Background: The association between cystatin C and risk of ischemic stroke is inconsistent and the cut-off values of cystatin C are diverse in different articles. We aimed to investigate the association between cystatin C levels and the development of ischemic stroke and to explore the clinical cut-off values of serum cystatin C levels for ischemic stroke. Methods: This prospective cohort study included 7658 participants from the China Health and Retirement Longitudinal Study who were free of cardiovascular diseases and cancer at baseline.
Source: Journal of Stroke and Cerebrovascular Diseases - September 1, 2019 Category: Neurology Authors: Youyi Wang, Ying Zhang, Qinghua Ma, Congju Wang, Yong Xu, Hongpeng Sun, Yana Ma Source Type: research
Ability of the number of territories involved on dwi-mri to predict occult systemic malignancy in cryptogenic stroke patients
Lesions in multiple arterial territories is one of the typical features of malignancy patients with cryptogenic stroke. Hence, if patients with cryptogenic stroke display such feature, occult cancer could be predicted. The study aimed to analyze the predictive ability of the number of territories involved on DWI-MRI for occult systemic malignancy (OSM) in patients with cryptogenic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - April 29, 2020 Category: Neurology Authors: Linjia Guo, Lili Wang, Wenhong Liu Source Type: research
Clinical Characteristics and Analysis of Lung Cancer- Associated Acute Ischemic Stroke
The incidence of lung cancer and acute ischemic stroke remains high in recent years, both of which occur mostly in people over 60 years old. In the present study, we aimed to further clarify the pathogenesis of lung cancer-associated acute ischemic stroke (LCA-AIS) by comparing and analyzing clinical characteristics of stroke patients with or without lung cancer.
Source: Journal of Stroke and Cerebrovascular Diseases - August 11, 2020 Category: Neurology Authors: Jing Zhang, Jingxia Zhao Source Type: research
Endovascular Therapy of Acute Ischemic Stroke in Patients with Large-Vessel Occlusion Associated with Active Malignancy
Approximately 15% of cancer patients have concomitant cerebrovascular disease.1,2 The frequency of ischemic and hemorrhagic stroke in this group of patients is similar to the general population2, and about one in ten stroke patients may have a concurrent malignancy.3 Intravenous thrombolysis (IVT) in these patients is often contraindicated and is used less frequently due to various possible comorbidities.4 While EVT is a well-established approach to treat acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO) 5,6,7,8, there is paucity of data with regards to EVT success and outcomes in patients with active malignancy.
Source: Journal of Stroke and Cerebrovascular Diseases - November 24, 2020 Category: Neurology Authors: Tomohiko Ozaki, Patrick Nicholson, Joanna D. Schaafsma, Ronit Agid, Timo Krings, Aleksandra Pikula, Vitor Mendes Pereira Source Type: research
